Clinical Roundup Long-term risks from prostate cancer treatment detailed in new report November 08, 2024Vol.50 No.42
Clinical Roundup Ruxolitinib improves CML’s response to standard TKI treatment November 08, 2024Vol.50 No.42
Clinical Roundup Quitting smoking after a cancer diagnosis improves survival November 08, 2024Vol.50 No.42
Clinical Roundup Survey shows dangerous knowledge gaps in pancreatic cancer November 08, 2024Vol.50 No.42
Clinical Roundup AI may be more accurate vs. traditional methods at classifying patients into prostate cancer risk groups November 08, 2024Vol.50 No.42
Clinical Roundup Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment November 08, 2024Vol.50 No.42
Clinical Roundup Preclinical data show anti-CD24 macrophage checkpoint inhibitor promotes phagocytosis and shrinks tumors November 08, 2024Vol.50 No.42
Clinical Roundup Scientists identify genes that help cancer cells survive in the bloodstream November 08, 2024Vol.50 No.42
Clinical Roundup RAS-mutant leukemia stem cells behave differently from other leukemia stem cells November 08, 2024Vol.50 No.42
Clinical Roundup NCCS releases “2024 State of Cancer Survivorship” data November 01, 2024Vol.50 No.41
